Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Reykjavik Political Voice.
Fossil Fuel Subsidy Reform Initiative reviews recent progress at closing meeting of 2024
World Trade Organization
·
November 26, 2024
Ambassador Clare Kelly of New Zealand, coordinator of the FFSR initiative, detailed recent work undertaken under the three pillars of the FFSR initiative in line with the 13th Ministerial Conference Ministerial Statement and associated work...
Tourism Source Market is slated to increase at a CAGR of 6.6% to reach a valuation of US$ 1.1 Trillion by 2032
EIN Presswire
·
March 18, 2025
By tourist type, the group segment dominated the global market and is likely to remain dominant during the forecast period. WILMINGTON, DE, UNITED STATES, March 18, 2025 /EINPresswire.com/ -- The Tourism Source Market Size was valued at $599.40...
Cesar Arevalo Promotes Nordic Music and Culture Through New Collaborations
EIN Presswire
·
October 24, 2024
TAMPA, FL, UNITED STATES, October 24, 2024 /EINPresswire.com/ -- Cesar Arevalo, the social media management guru and former Azul Night TV producer, recently returned to Tampa from his trip to Europe after visiting Scandinavian countries as part...
Ukraine Compact
Prime Minister of Canada
·
July 12, 2024
CANADA, December 7 - We the leaders of the United States of America, Belgium, Canada, Denmark, Estonia, Finland, France, Germany, Iceland, Italy, Japan, Latvia, Lithuania, Luxembourg, the Netherlands, Norway, Poland, Portugal, Romania, Spain,...
DDG Paugam: Climate crisis requires scaled-up response from trade community
World Trade Organization
·
November 15, 2024
Your Excellencies, dear colleagues, friends, Thank you for the invitation from the Coalition of Trade Ministers for Climate. I am honored to be here today. Since its creation the WTO Secretariat has been working closely with the Coalition and its...
VIVUS Unveils Global Initiative to Advance Healthy and Sustainable Weight Management
GlobeNewswire, Inc.
·
March 4, 2025
VIVUS reaffirms commitment to combatting global obesity crisis on World Obesity Day 2025 with VIVUS For Life CAMPBELL, Calif., March 04, 2025 (GLOBE NEWSWIRE) -- VIVUS, LLC., a biopharmaceutical company committed to the development and...
Air Traffic Control Market Projected Grows From $11.0 Billion in 2023 to $24.7 Billion by 2033
EIN Presswire
·
March 3, 2025
In December 2023, Thales Group, a leader in aerospace, defense, security, and digital identity, established an Air Traffic Management Service Center in Mexico. WILMINGTON, NEW CASTLE, DE, UNITED STATES, March 4, 2025 /EINPresswire.com/ --...
Costco Wholesale Corporation Reports Second Quarter and Year-To-Date Operating Results For Fiscal 2025 and February Sales Results
GlobeNewswire, Inc.
·
March 6, 2025
ISSAQUAH, Wash., March 06, 2025 (GLOBE NEWSWIRE) -- Costco Wholesale Corporation (“Costco” or the “Company”) (Nasdaq: COST) today announced its operating results for the second quarter (twelve weeks) and the first 24 weeks of fiscal 2025, ended...
Oculis Reports Q3 2024 Financial Results and Provides Company Updates
GlobeNewswire, Inc.
·
November 7, 2024
Significant advancement on product portfolio, including enrollment in the OCS-01 DIAMOND Phase 3 program in DME and OCS-05 Phase 2 ACUITY trial in acute optic neuritis (AON) with topline readout anticipated in December 2024 Leadership team...
The Arctic This Week Take Five: Week of 28 October, 2024
The Arctic Institute
·
November 1, 2024
Back to Publications Norway Reduces Funding for Arctic Cultural Cooperation in 2025 Budget High North News reported on October 30 that in its 2025 national budget, the Norwegian government has proposed a NOK 4 million reduction in funds for...
Oculis to Present at the Stifel 2024 Healthcare Conference
GlobeNewswire, Inc.
·
November 13, 2024
ZUG, Switzerland, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS) (“Oculis”), a global biopharmaceutical company purposefully driven to save sight and improve eye care, today announced that Oculis’ management will be present at...
Ligand Reports Fourth Quarter and Full Year 2024 Financial Results
GlobeNewswire, Inc.
·
February 27, 2025
Robust financial performance driven by full year 2024 royalty revenue growth of 28% Reiterating 2025 financial guidance of $180-$200 million in revenues and adjusted earnings per diluted share1 of $6.00-$6.25 Conference call and webcast at 8:30...
Outside In Theatre Presents "In Honor of Jean-Michel Basquiat" by Roger Guenveur Smith
EIN Presswire
·
February 26, 2025
See this powerful live performance this March. Performances March 13 - 30, 2025 Thursdays, Fridays, Saturdays & Sundays at 8pm LOS ANGELES, CA, UNITED STATES, February 25, 2025 /EINPresswire.com/ -- Outside In Theatre is thrilled to announce the...
(Video) Report: Iranian Resistance Activities and Achievements in 2024
EIN Presswire
·
January 6, 2025
In Nov. 2024, the UK House of Lords met with Iranian Resistance supporters, stressing women’s leadership, global support for Maryam Rajavi’s 10 points plan. PARIS, FRANCE, January 6, 2025 /EINPresswire.com/ -- The National Council of Resistance...
Century Aluminum Company Reports Fourth Quarter 2024 Results
GlobeNewswire, Inc.
·
February 20, 2025
CHICAGO, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Century Aluminum Company (NASDAQ: CENX) today announced its fourth quarter and full year 2024 results. Fourth Quarter 2024 Highlights Net sales $631.0 million Reported net income attributable to Century...
Teva and Alvotech Announce SELARSDI™ (ustekinumab-aekn) Injection Now Available in the U.S.
GlobeNewswire, Inc.
·
February 21, 2025
In October 2024, the U.S. Food and Drug Administration (FDA) approved SELARSDI™ for all indications matching the reference product Stelara® (ustekinumab) and has granted a provisional determination of interchangeability for SELARSDI SELARSDI is...
Alvotech and Teva Announce U.S. FDA Approval of Additional Presentation of SELARSDI™ (ustekinumab-aekn), Expanding its Label to Include Further Indications Approved for Reference Product, Stelara® (ustekinumab)
GlobeNewswire, Inc.
·
October 22, 2024
Approval of SELARSDI 130 mg/26 mL in a single-dose vial for intravenous infusion expands label to include treatment of adults with Crohn’s disease and ulcerative colitis The FDA previously approved SELARSDI 45 mg/0.5 mL and 90 mg/mL in a...
PyroGenesis Announces First Material Produced from Fumed Silica Reactor
GlobeNewswire, Inc.
·
February 27, 2025
MONTREAL, Feb. 27, 2025 (GLOBE NEWSWIRE) -- PyroGenesis Inc. (“PyroGenesis”) (http://pyrogenesis.com) (TSX: PYR) (OTCQX: PYRGF) (FRA: 8PY1), a high-tech company that designs, develops, manufactures and commercializes all-electric plasma processes...
Oculis Accelerates Enrollment in both DIAMOND Phase 3 Trials of OCS-01 in Diabetic Macular Edema and Expands its DIAMOND Program Committees
GlobeNewswire, Inc.
·
October 21, 2024
Phase 3 DIAMOND-1 and DIAMOND-2 trials enrollment of OCS-01 in diabetic macular edema (DME) accelerated with great momentum DIAMOND program committees expanded with globally renowned retina experts If approved, OCS-01 has the potential to...
The Artificial Limbs Global Market: Noteworthy Growth and Standout Trends Taking Shape in the Coming Years
EIN Presswire
·
February 12, 2025
The Business Research Company's Artificial Limbs Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, February 12, 2025 /EINPresswire.com/ -- Updated 2025 Market Reports Released:...